Deerfield Beach, FL -- (SBWIRE) -- 06/21/2017 -- New report on Asthma and COPD Drug (Chronic Obstructive Pulmonary Disease) are chronic diseases characterized by airway obstruction in the lungs causing respiratory infection and fatigue. COPD is characterized by yellow phlegm in the cough and episodes of cough and wheezing at night are the characteristics of asthma. Asthma and COPD drugs are the drugs that are used to treat symptoms of Asthma and COPD. These medications are generally prescribed by the pharmacists, practitioners, asthma educators, respiratory physicians, practice nurses and allergists. Traditional therapies include anti-inflammatory glucocorticosteroid and inhaled bronchodilator. Use of these therapies results in adverse effects and sometimes may worsen the symptoms of asthma and COPD. Drug treatment of asthma mainly aims at the symptomatic relief and disease modification. Drug treatment also prevents lung damage and reduces inflammation. Increased awareness about the timely diagnosis, early stage treatment of Asthma and COPD are creating opportunities for the growth of the market. Many companies are adopting CMO (contract manufacturing outsourcing) and focusing on new product development. This shows huge opportunity for the enlargement and expansion of the market.

Get Free Sample Report Of Asthma and COPD Drug Market @ http://www.marketresearchstore.com/report/world-asthma-and-copd-drug-market-opportunities-68417#RequestSample

The growth of the Asthma and COPD drugs market is driven by the factors such as raised level of pollution and increasing aging population. Advanced therapies of medical cure and rising disposable income are also contributing to the growth of the market. However, high cost of some of the drugs and loss of patents of major Asthma and COPD drugs are the major factors that are hampering the growth of the market. Rising entry of beta-agonists, combinational therapies and inhaled corticosteroids are few of the challenges that Asthma and COPD drugs Market is facing. Asthma and COPD Drug product market is segmented into combination therapies, anti- inflammatories, and bronchodilators. Anti- inflammatories can be further segment into monoclonal antibodies, anti- leukotriene and inhaled corticosteroids. Bronchodilators can also be further segmented into anticholonergics, long acting bronchodilators and short acting bronchodilators. Bronchodilators segment is the largest revenue generating segment due to its long- acting bronchodilators drugs that can treat the symptoms of COPD quickly. Long- acting bronchodilators drugs are considered to be the best cure for COPD.

Do Inquiry To Buy Report Of Asthma and COPD Drug Market @ http://www.marketresearchstore.com/report/world-asthma-and-copd-drug-market-opportunities-68417#InquiryForBuying

Market by Product

Combination Therapies
Anti- Inflammatories
Monoclonal Antibodies
Anti- Leukotriene
Inhaled Corticosteroids
Bronchodilators
Anticholonergics
Long Acting Bronchodilators
Short Acting Bronchodolators

Market by Geography

North America
Europe
Asia Pacific
RoW